| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Dasatinib | GDSC1000 | pan-cancer | AAC | -0.043 | 0.4 |
| mRNA | apicidin | CTRPv2 | pan-cancer | AAC | 0.025 | 0.4 |
| mRNA | FGIN-1-27 | CTRPv2 | pan-cancer | AAC | 0.058 | 0.4 |
| mRNA | BRD-K16147474 | CTRPv2 | pan-cancer | AAC | -0.032 | 0.4 |
| mRNA | RDEA119 | GDSC1000 | pan-cancer | AAC | -0.027 | 0.4 |
| mRNA | LY-2157299 | CTRPv2 | pan-cancer | AAC | 0.058 | 0.4 |
| mRNA | NU-7441 | GDSC1000 | pan-cancer | AAC | -0.032 | 0.4 |
| mRNA | selumetinib:navitoclax (8:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.029 | 0.4 |
| mRNA | XL765 | CTRPv2 | pan-cancer | AAC | 0.03 | 0.4 |
| mRNA | pac-1 | CTRPv2 | pan-cancer | AAC | 0.029 | 0.4 |